Cargando…

Elimination of onchocerciasis in Ecuador: findings of post-treatment surveillance

BACKGROUND: The Esmeraldas focus of onchocerciasis in Ecuador expanded geographically during the 1980s and was associated with severe ocular and skin disease. Mass drug administration (MDA) with ivermectin started in 1991, initially once but later twice a year, in the principle endemic focus followe...

Descripción completa

Detalles Bibliográficos
Autores principales: Guevara, Ángel, Lovato, Raquel, Proaño, Roberto, Rodriguez-Perez, Mario A., Unnasch, Thomas, Cooper, Philip J., Guderian, Ronald H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937837/
https://www.ncbi.nlm.nih.gov/pubmed/29690907
http://dx.doi.org/10.1186/s13071-018-2851-3
_version_ 1783320690573705216
author Guevara, Ángel
Lovato, Raquel
Proaño, Roberto
Rodriguez-Perez, Mario A.
Unnasch, Thomas
Cooper, Philip J.
Guderian, Ronald H.
author_facet Guevara, Ángel
Lovato, Raquel
Proaño, Roberto
Rodriguez-Perez, Mario A.
Unnasch, Thomas
Cooper, Philip J.
Guderian, Ronald H.
author_sort Guevara, Ángel
collection PubMed
description BACKGROUND: The Esmeraldas focus of onchocerciasis in Ecuador expanded geographically during the 1980s and was associated with severe ocular and skin disease. Mass drug administration (MDA) with ivermectin started in 1991, initially once but later twice a year, in the principle endemic focus followed by all satellite foci. Treatment was stopped in 2009 when entomological assessments determined that transmission of Onchocerca volvulus had been interrupted. METHODS: Three years after the cessation of ivermectin treatment in 2012, as defined by the WHO guidelines for onchocerciasis elimination, blackfly collections were done in four sentinel sites in former hyperendemic areas. The presence of infective larvae in local vectors, Simulium exiguum and Simulum quadrivittatum, was assessed by detection of O. volvulus DNA by PCR. Additional flies captured in four extra-sentinel sites located in former hyper- and mesoendemic dispersed isolated areas were also assessed. RESULTS: The results from 68,310 captured blackflies, 40,114 from four sentinel villages in the previously hyperendemic areas (Corriente Grande, El Tigre, San Miguel on Río Cayapas and Naranjal on Río Canandé) and 28,197 from extra-sentinel locations, were all negative for the presence of O. volvulus. These extra-sentinel sites (Hualpí on Río Hoja Blanca, Capulí on Río Onzole, La Ceiba on Río Tululví and Medianía on Río Verde) were included to provide additional evidence of the impact of MDA on the transmission of O. volvulus in isolated endemic areas. CONCLUSIONS: Our data indicate that transmission of O. volvulus has been stopped in all endemic areas in Ecuador, including all satellite foci outside the main focus. These findings indicate that a strategy of ivermectin distribution twice a year to over 85% of the treatment-eligible population was effective in eliminating the infection from Ecuador in a focus with a highly competent primary vector, S. exiguum, and where the infection rates were equal to or greater than observed in many onchocerciasis foci in Africa.
format Online
Article
Text
id pubmed-5937837
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59378372018-05-14 Elimination of onchocerciasis in Ecuador: findings of post-treatment surveillance Guevara, Ángel Lovato, Raquel Proaño, Roberto Rodriguez-Perez, Mario A. Unnasch, Thomas Cooper, Philip J. Guderian, Ronald H. Parasit Vectors Research Article BACKGROUND: The Esmeraldas focus of onchocerciasis in Ecuador expanded geographically during the 1980s and was associated with severe ocular and skin disease. Mass drug administration (MDA) with ivermectin started in 1991, initially once but later twice a year, in the principle endemic focus followed by all satellite foci. Treatment was stopped in 2009 when entomological assessments determined that transmission of Onchocerca volvulus had been interrupted. METHODS: Three years after the cessation of ivermectin treatment in 2012, as defined by the WHO guidelines for onchocerciasis elimination, blackfly collections were done in four sentinel sites in former hyperendemic areas. The presence of infective larvae in local vectors, Simulium exiguum and Simulum quadrivittatum, was assessed by detection of O. volvulus DNA by PCR. Additional flies captured in four extra-sentinel sites located in former hyper- and mesoendemic dispersed isolated areas were also assessed. RESULTS: The results from 68,310 captured blackflies, 40,114 from four sentinel villages in the previously hyperendemic areas (Corriente Grande, El Tigre, San Miguel on Río Cayapas and Naranjal on Río Canandé) and 28,197 from extra-sentinel locations, were all negative for the presence of O. volvulus. These extra-sentinel sites (Hualpí on Río Hoja Blanca, Capulí on Río Onzole, La Ceiba on Río Tululví and Medianía on Río Verde) were included to provide additional evidence of the impact of MDA on the transmission of O. volvulus in isolated endemic areas. CONCLUSIONS: Our data indicate that transmission of O. volvulus has been stopped in all endemic areas in Ecuador, including all satellite foci outside the main focus. These findings indicate that a strategy of ivermectin distribution twice a year to over 85% of the treatment-eligible population was effective in eliminating the infection from Ecuador in a focus with a highly competent primary vector, S. exiguum, and where the infection rates were equal to or greater than observed in many onchocerciasis foci in Africa. BioMed Central 2018-04-24 /pmc/articles/PMC5937837/ /pubmed/29690907 http://dx.doi.org/10.1186/s13071-018-2851-3 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Guevara, Ángel
Lovato, Raquel
Proaño, Roberto
Rodriguez-Perez, Mario A.
Unnasch, Thomas
Cooper, Philip J.
Guderian, Ronald H.
Elimination of onchocerciasis in Ecuador: findings of post-treatment surveillance
title Elimination of onchocerciasis in Ecuador: findings of post-treatment surveillance
title_full Elimination of onchocerciasis in Ecuador: findings of post-treatment surveillance
title_fullStr Elimination of onchocerciasis in Ecuador: findings of post-treatment surveillance
title_full_unstemmed Elimination of onchocerciasis in Ecuador: findings of post-treatment surveillance
title_short Elimination of onchocerciasis in Ecuador: findings of post-treatment surveillance
title_sort elimination of onchocerciasis in ecuador: findings of post-treatment surveillance
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937837/
https://www.ncbi.nlm.nih.gov/pubmed/29690907
http://dx.doi.org/10.1186/s13071-018-2851-3
work_keys_str_mv AT guevaraangel eliminationofonchocerciasisinecuadorfindingsofposttreatmentsurveillance
AT lovatoraquel eliminationofonchocerciasisinecuadorfindingsofposttreatmentsurveillance
AT proanoroberto eliminationofonchocerciasisinecuadorfindingsofposttreatmentsurveillance
AT rodriguezperezmarioa eliminationofonchocerciasisinecuadorfindingsofposttreatmentsurveillance
AT unnaschthomas eliminationofonchocerciasisinecuadorfindingsofposttreatmentsurveillance
AT cooperphilipj eliminationofonchocerciasisinecuadorfindingsofposttreatmentsurveillance
AT guderianronaldh eliminationofonchocerciasisinecuadorfindingsofposttreatmentsurveillance